- Published
- 2022-09-26
- Venue
- The Lancet Oncology, vol. 23, no. 10, pp. e450-e458
- Cited by
- 525
- Open access
- Yes, bronze
- DOI
- 10.1016/s1470-2045(22)00372-2
- PubMed
- 36174631
Cite this paper
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
- APA 7
Lorentzen, C. L., Haanen, J. B., Met, Ö., & Svane, I. M. (2022). Clinical advances and ongoing trials of mRNA vaccines for cancer treatment. The Lancet Oncology, 23(10), e450–e458. https://doi.org/10.1016/s1470-2045(22)00372-2
- MLA 9
Lorentzen, Cathrine Lund, et al. "Clinical advances and ongoing trials of mRNA vaccines for cancer treatment." The Lancet Oncology, vol. 23, no. 10, 2022, pp. e450–e458, https://doi.org/10.1016/s1470-2045(22)00372-2.
- Chicago
Lorentzen, Cathrine Lund, John B.A.G. Haanen, Özcan Met, and Inge Marie Svane. "Clinical advances and ongoing trials of mRNA vaccines for cancer treatment." The Lancet Oncology 23, no. 10 (2022): e450–e458. https://doi.org/10.1016/s1470-2045(22)00372-2.
- GOST
Lorentzen C. L., Haanen J. B., Met Ö. [и др.] Clinical advances and ongoing trials of mRNA vaccines for cancer treatment // The Lancet Oncology. — 2022. — Vol. 23, № 10. — P. e450–e458. — URL: https://doi.org/10.1016/s1470-2045(22)00372-2
- BibTeX
@article{lorentzen2022clinical, title = {{Clinical advances and ongoing trials of mRNA vaccines for cancer treatment}}, author = {Cathrine Lund Lorentzen and John B.A.G. Haanen and Özcan Met and Inge Marie Svane}, journal = {The Lancet Oncology}, year = {2022}, volume = {23}, number = {10}, pages = {e450--e458}, doi = {10.1016/s1470-2045(22)00372-2}, url = {https://doi.org/10.1016/s1470-2045(22)00372-2} }- RIS
TY - JOUR AU - Lorentzen, Cathrine Lund AU - Haanen, John B.A.G. AU - Met, Özcan AU - Svane, Inge Marie TI - Clinical advances and ongoing trials of mRNA vaccines for cancer treatment JO - The Lancet Oncology VL - 23 IS - 10 SP - e450 EP - e458 PY - 2022 DA - 2022/09/26 DO - 10.1016/s1470-2045(22)00372-2 UR - https://doi.org/10.1016/s1470-2045(22)00372-2 ER -